Amir Reichman - 18 Mar 2026 Form 3 Insider Report for Scinai Immunotherapeutics Ltd. (SCNI)

Role
Chief Executive Officer, Director
Signature
/s/ Amir Reichman
Issuer symbol
SCNI
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 09:53:02 UTC
Previous filing
03 Jan 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reichman Amir Chief Executive Officer, Director C/O SCINAI IMMUNOTHERAPEUTICS LTD., JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, ISRAEL /s/ Amir Reichman 18 Mar 2026 0001960199

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SCNI Ordinary shares, no par value per share 311,637,600 18 Mar 2026 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SCNI American Depositary Shares 18 Mar 2026 Ordinary Shares 67,540,000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.
F2 Includes 71,637,600 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on January 25, 2024, of which 25% vested on the six-month anniversary thereof, 8.33% vested on the 12-month anniversary thereof, and 66.66% vest in two equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Each RSU represents a contingent right to receive one Ordinary Share upon vesting.
F3 Includes 240,000,000 Ordinary Shares that are represented by RSUs that were granted on December 22, 2025, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.
F4 Represents 16,885 American Depositary Shares, which are convertible at any time into 67,540,000 Ordinary Shares, at the holder's election and have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney.